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Background: Four oscillometric devices for self-measurement of blood pressure (SBPM) were 
evaluated according to the European Society of Hypertension (ESH) international protocol and 
its 2010 revision in four separate studies. The Omron® M2, Omron M3, and Omron M6 measure 
blood pressure (BP) at the brachial level, while the Omron R2 measures BP at the wrist level.
Methods: The international protocol requires a total number of 33 subjects in which the validation 
is performed. The Omron M2 and Omron R2 were validated in 2009 according to the ESH inter-
national protocol, while the Omron M3 and Omron M6 were validated in 2010–2011 according to 
the 2010 ESH international protocol revision. The protocol procedures were   followed precisely.
Results: All four tested devices passed the validation process. The mean differences between 
the device and mercury readings were 2.7 ± 5.0 and −1.4 ± 3.2 mmHg for systolic and dia-
stolic BP, respectively, using the Omron M2 device, and 1.7 ± 3.2 and −0.9 ± 2.6 mmHg 
using the Omron M3, 1.6 ± 2.9 and −0.9 ± 2.5 mmHg using the Omron M6, and −1.1 ± 4.8 
and −0.9 ± 4.3 mmHg using the Omron R2.
Conclusion: Readings from the Omron M2, Omron M3, Omron M6, and Omron R2, differing 
by less than 5, 10, and 15 mmHg, fulfill the ESH international protocol and its 2010 revision 
requirements. Therefore, each of these four devices can be used by patients for SBPM.
Keywords: Omron R2, M2, M3, M6, blood pressure measurement, validation, international 
protocol, European Society of Hypertension
Introduction
The advantages of blood pressure (BP) self-measurement have been well documented.1,2 
Indeed, self-BP measurement (SBPM) not only provides valuable information for 
diagnosis of hypertension but also for BP control in the treated patient, and improves 
patient compliance with antihypertensive therapy.1–3 Therefore, it is appropriate to 
encourage widespread use of SBPM as an important adjunct to the clinical care of 
patients with hypertension.2 Clinical indications for SBPM have recently been high-
lighted in several guidelines and consensus conferences.1–6 Obviously, SBPM is only 
practicably useful if the devices are user-friendly and accurate. Recommended devices 
for SBPM should be submitted to independent validation procedures. Currently, only a 
few of the devices available on the market have been validated and are recommended 
for patient use.7 Validation has to be performed according to recognized protocols spe-
cifically designed for this purpose, such as the British Hypertension Society protocol,8 
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international protocol published by the European Society 
of Hypertension (ESH).10,11 In this study, four devices for 
SBPM were validated according to the international protocol 
in four separate studies.
Methods and materials
Devices
Omron M2
The Omron® M2 (HEM-7117-E) device records brachial 
BP using the oscillometric method with a pressure range of 
0–299 mmHg and pulse rate range of 40–180 beats/minute. 
Systolic BP, diastolic BP, and pulse rate are displayed on a 
liquid crystal digital (LCD) screen. The device can detect and 
display a symbol on the LCD screen if an irregular heart beat 
defined by a heart beat rhythm that varies by more than 25% 
from the average heart beat rhythm is detected while the unit 
is measuring the systolic and diastolic BP. It includes memory 
for 21 measurements. The unit weighs approximately 260 g 
without batteries. Four AAA batteries are needed with an 
approximate capacity of 300 measurements. The standard 
cuff included is applicable to arm circumferences ranging 
from 22 to 32 cm; a large cuff is also available for arm cir-
cumferences of 32–42 cm.
Omron M3
The Omron M3 (HEM-7200-E) device records brachial 
BP using the oscillometric method with a pressure range of 
0–299 mmHg and pulse rate range of 40–180 beats/minute. 
Inflation is performed using a fuzzy-logic electric pumping 
system and deflation by an automatic pressure release valve. 
At the end of each measurement, systolic BP, diastolic BP, 
and pulse rate are displayed on a LCD screen. The device can 
detect and display a symbol on the LCD screen if an irregular 
heart beat defined by a heart beat rhythm that varies by more 
than 25% from the average heart beat rhythm is detected while 
the unit is measuring the systolic and diastolic BP. The monitor 
automatically stores results for up to 60 sets. It can also calculate 
an average reading based on measurements from the last three 
readings taken within 10 minutes. The unit weighs approxi-
mately 340 g without batteries. Four AA alkaline batteries are 
needed with an approximate capacity for 1500 measurements. 
Two sizes of cuffs, ie, standard and large, are available. The 
standard cuff is adapted to an arm circumference of 22–32 cm 
and the large cuff to an arm circumference of 32–42 cm.
Omron M6
The Omron M6 (HEM-7211-E) device records brachial BP 
using the oscillometric method with a pressure range of 
0–299 mmHg and pulse rate range of 40–180 beats/minute. 
Inflation is performed using a fuzzy-logic electric pumping 
system and deflation by an automatic pressure release valve. 
At the end of each measurement, systolic BP, diastolic BP, 
and pulse rate are displayed on a LCD screen. The device can 
detect and display a symbol on the LCD screen if an irregu-
lar heart beat defined by a heart beat rhythm that varies by 
more than 25% from the average heart beat rhythm detected 
while the unit is measuring the systolic and diastolic BP. The 
monitor automatically stores results for up to 90 sets. It can 
also calculate an average reading based on measurements 
from the last three readings taken within 10 minutes. The 
unit weighs approximately 380 g without batteries. Four AA 
alkaline batteries are needed with an approximate capacity for 
1500 measurements. Three sizes of cuffs, ie, small, standard, 
and large, are available. The standard cuff is adapted to an 
arm circumference of 22–32 cm, the small cuff to an arm 
circumference of 17–22 cm, and the large cuff to an arm 
circumference of 32–42 cm.
Omron R2
The Omron R2 (HEM-6113-E) device is an automatic oscil-
lometric device for SBPM, measuring radial BP at the wrist 
level. This device uses automatic inflation by pump and auto-
matic rapid deflation. It measures a BP range of 1–299 mmHg 
and a pulse rate range of 40–180 beats/minute, and values 
are displayed on a LCD screen. The unit includes memory 
for 30 measurements. It weighs approximately 117 g without 
batteries. Two AAA alkaline batteries are needed with an 
approximate capacity for 300 measurements. The device can 
be used for wrist circumferences of 13.5–21.5 cm.
BP measurements
For each study, the manufacturer was asked to provide three 
complete devices, declared by the manufacturer as standard 
production models. Before the validation study per se, 
a familiarization period of about one week took place in 
an outpatient clinic. During this period, the investigators 
familiarized themselves with use of the tested device. Each 
validation study was performed using one device chosen 
randomly by the investigator from the three provided by the 
manufacturer.
The validation team for each study consisted of three per-
sons experienced in BP measurement. Investigators underwent 
training on the basis of a CD-ROM specifically developed by 
the French Society of Hypertension for the certification of 
observers involved in clinical studies. Two of the three observers 
measured BP using a teaching stethoscope for simultaneous Vascular Health and Risk Management 2011:7 submit your manuscript | www.dovepress.com
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measurements (Y tube, Littmann, Schaumburg, IL) and two 
standard mercury sphygmomanometers, the components of 
which had been carefully checked before the study. The third 
observer was the supervisor who checked the agreement of 
BP values obtained by the two observers who were blinded 
to each other’s readings. In one study (of the Omron M6), the 
second observer was also the supervisor (JT).
Patient population
The four validation studies were performed in the general 
population. According to the international protocol, a total 
of 33 participants who fulfilled the age, gender, and entry BP 
requirements (age $25 years, at least 10 men and 10 women, 
11 participants with entry BP within each of the ranges 
90–129 mmHg, 130–160 mmHg, and 161–180 for systolic 
BP and 40–79 mmHg, 80–100 mmHg, and 101–130 mmHg 
for diastolic BP). Arm circumference is distributed by chance. 
In order to optimize recruitment, it was recommended that 
subjects for the high diastolic BP and low systolic BP groups 
should be recruited first, then those with high systolic BP 
and low diastolic BP, and finally the remaining gaps should 
be filled. In these four studies, subjects were preselected in 
order to avoid a high number of subjects being excluded 
because of their BP range.
Procedure
Subjects were seated in a quiet room and BP measurements 
started after a 10-minute rest period. Arm circumference was 
measured and the cuff size was adapted. All measurements 
were performed in the left arm at the heart level. BP was mea-
sured simultaneously by the two observers alternately with 
the automatic device as mentioned earlier. Nine consecutive 
measurements were carried out according to the procedure 
described in detail elsewhere.10 The validation studies of 
the Omron R2 and the Omron M2 were performed during 
the last quarter of 2009 according to the first version of the 
international protocol;10 those for the Omron M3 and the 
Omron M6 were performed at the end of 2010 and 2011 
according to the 2010 international protocol revision. In 
each of the four studies, the ESH International protocol and 
its revision 2010 were followed precisely.
Data analysis
Differences between the tested device and control mea-
surements were classified according to whether they were 
within 5, 10, or 15 mmHg. Differences were calculated 
by subtracting the observer measurement from the device 
measurement; they were classified separately in this way for 
both systolic BP and diastolic BP. The number of differences 
in each zone was calculated and compared with the number 
required by the international protocol and its 2010 revision. 
Details of the analysis procedure have already been published 
elsewhere.10,11
Results
Omron M2
This study included 33 subjects (20 men and 13 women) 
with a mean age of 58 ± 11 (range 37–80) years, and a mean 
arm circumference of 28 ± 4 (range 20–34) cm. A standard 
size cuff was used in 30 subjects and a large cuff in three 
subjects. At entry, the mean BP values were, respectively, 
142 ± 23 (range 101–180) mmHg for systolic BP and 
86 ± 18 (range 53–110) mmHg for diastolic BP. The dif-
ference between the two observers was 0.1 ± 2.1 mmHg 
and 0.3 ± 2.1 mmHg for systolic BP and diastolic BP, 
  respectively. The mean differences between the observers 
and the tested device were 2.7 ± 5.0 and −1.4 ± 3.2 mmHg 
for systolic BP and diastolic BP, respectively.
The numbers of measurements differing from the mer-
cury standard by 5, 10, and 15 mmHg or less are shown in 
Table 1. The difference between the device readings and the 
mean BP of the device and the two observers for all 99 points 
of systolic BP and diastolic BP are displayed in Figure 1. 
These results are in agreement with the international protocol 
requirements for the primary and secondary phases. Thus, 
the Omron M2 device fulfills the validation criteria of the 
international protocol.
Omron M3
This study included 33 subjects (16 men and 17 women) with 
a mean age of 60 ± 11 (range 31–78) years and a mean arm 
circumference of 29 ± 3 (range 25–36) cm. A standard size 
cuff was used in 29 subjects and a large cuff in four subjects. 
At entry, the mean BP values were, respectively, 142 ± 25 
(range 90–179) mmHg for systolic BP and 85 ± 18 (range 
50–119) mmHg for diastolic BP. The difference between 
the two observers was 0.1 ± 0.8 and −0.2 ± 1.0 mmHg for 
systolic BP and diastolic BP, respectively. The mean dif-
ferences between the observers and the tested device were 
1.7 ± 3.2 and −0.9 ± 2.6 mmHg for systolic BP and diastolic 
BP, respectively.
The numbers of measurements differing from the mer-
cury standard by 5, 10, and 15 mmHg or less are shown in 
Table 2. The difference between the device readings and the 
mean BP of the device and the two observers for all 99 points 
of systolic BP and diastolic BP are displayed in Figure 2. Vascular Health and Risk Management 2011:7
Table 1 Results for the Omron M2 device according to the eSH international protocol
Phase 1 #5 mmHg #10 mmHg #15 mmHg Recommendation
Required One of 25 35 40
Achieved SBP 23 38 42 Continue
DBP 40 45 45 Continue
Phase 2.1 #5 mmHg #10 mmHg #15 mmHg Recommendation Mean difference  
(mmHg)
SD
Required Two of 65 80 95
All of 60 75 90
Achieved SBP 73 92 96 Pass 2.7 5.0
DBP 88 99 99 Pass −1.4 3.2
Phase 2.2 2/3 # 5 mmHg 0/3 # 5 mmHg Recommendation
Required $22 #3
Achieved SBP 25 3 Pass
DBP 31 0 Pass
Abbreviations: eSH, european Society for Hypertension; SD, standard deviation (mmHg); SDP, systolic blood pressure; DBP, diastolic blood pressure.
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These results are in concordance with the 2010 international 
protocol revision requirements. Thus, the Omron M3 device 
fulfills the validation criteria of the 2010 ESH international 
protocol revision.
Omron M6
This study included 33 subjects (15 men and 18 women) with 
a mean age of 60 ± 13 (range 25–79) years and a mean arm 
circumference of 29 ± 3 (range 25–36) cm. A standard size cuff 
was used in 32 subjects and a large cuff in one subject. At entry, 
the mean BP values were, respectively, 144 ± 25 (range 96–180) 
mmHg for systolic BP and 86 ± 18 (range 50–119) mmHg for 
diastolic BP. The difference between the two observers was 
0.2 ± 1.1 and −0.1 ± 1.1 mmHg for systolic BP and diastolic 
BP, respectively. The mean differences between the observers 
and the tested device were 1.6 ± 2.9 and −0.9 ± 2.5 mmHg for 
systolic BP and diastolic BP, respectively.
The numbers of measurements differing from the mer-
cury standard by 5, 10, and 15 mmHg or less are shown in 
Table 3. The difference between the device readings and the 
mean BP of the device and the two observers for all 99 points 
of systolic BP and diastolic BP are displayed in Figure 3. 
These results are in concordance with the 2010 international 
protocol revision requirements. Thus, the Omron M6 device 
fulfills the validation criteria of the 2010 ESH international 
protocol revision.
Omron R2
This study included 33 subjects (19 men and 14 women) 
with a mean age of 58 ± 11 (range 37–80) years and a mean 
wrist circumference of 18 ± 2 (range 14–22) cm. A stan-
dard brachial size cuff was used in 31 subjects and a large 
cuff in two subjects. At entry, the mean BP values were, 
  respectively, 142 ± 24 (range 101–179) mmHg for systolic 
BP and 86 ± 18 (range 53–111) mmHg for diastolic BP. 
The difference between the two observers was 0.3 ± 2.2 
and 0.3 ± 1.8 mmHg for systolic BP and diastolic BP, 
  respectively. The mean differences between the observers 
and the tested device were −1.1 ± 4.8 and −0.9 ± 4.3 mmHg 
for systolic BP and diastolic BP, respectively.
The numbers of measurements differing from the mercury 
standard by 5, 10, and 15 mmHg or less are shown in Table 4. 
The difference between the device readings and the mean 
BP of the device and the two observers for all 99 points of 
systolic BP and diastolic BP are displayed in Figure 4. These 
results are in concordance with the requested criteria of the 
international protocol for the primary and secondary phases. 
Thus, the Omron R2 device fulfills the validation criteria of 
the international protocol.
Discussion
This study provides information on the accuracy of four 
devices for SBPM measurement. The Omron M2, Omron M3, 
and Omron M6 measure BP at the brachial level, whereas the 
Omron R2 measures radial BP at the wrist level. The results 
show that all four devices met the validation requirements 
of the ESH international protocol and its 2010 revision, 
provided that they are used by well trained observers and 
considering the factors affecting measurement accuracy as 
described by the manufacturers. The Omron M2 and R2 were 
validated according to the international protocol   version 
2002 because these studies were performed during the last 
quarter of 2009, whereas the Omron M3 and Omron M6 
were validated according to the 2010 international protocol 
revision because these two studies were performed after its 
publication during 2010 and 2011.Vascular Health and Risk Management 2011:7
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Figure 1 Plots of systolic (A) and diastolic (B) blood pressure differences between the Omron M2 readings and the mean of two observer readings in 33 participants (n = 99).
Table 2 Results for the Omron M3 device according to the eSH international protocol revision 2010
Part 1 #5 mmHg #10 mmHg #15 mmHg Grade 1 Mean difference SD
Required Two of 73 87 96
All of 65 81 93
Achieved SBP 86 99 99 Pass 1.7 3.2
DBP 94 99 99 Pass −0.9 2.6
Part 2 2/3 # 5 mmHg 0/3 # 5 mmHg Grade 2 Grade 3
Required $24 #3
Achieved SBP 31 0 Pass Pass
DBP 33 0 Pass Pass
Part 3 PASS
Abbreviations: eSH, european Society for Hypertension; SD, standard deviation (mmHg); SDP, systolic blood pressure; DBP, diastolic blood pressure.
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The four present validation studies were performed by 
well trained observers, who used the tested devices as rec-
ommended by the manufacturers and considered the factors 
affecting measurement accuracy. The latter is particularly 
important for the wrist BP device. BP measurements at the 
wrist level are prone to a number of errors, most of them 
related to how the patient uses the device. The wrist cuff 
has to be wrapped in a correct way and measurements per-
formed in the correct posture, ie, the arm held across the 
chest, the wrist at the heart level, the arm relaxed without Vascular Health and Risk Management 2011:7
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Figure 2 Plots of systolic (A) and diastolic (B) blood pressure differences between the Omron M3 readings and mean of the two observer readings in 33 participants (n = 99).
Table 3 Results for the Omron M6 device according to the eSH international protocol revision 2010
Part 1 #5 mmHg #10 mmHg #15 mmHg Grade 1 Mean difference SD
Required Two of 73 87 96
All of 65 81 93
Achieved SBP 89 99 99 Pass 1.6 2.9
DBP 96 99 99 Pass −0.9 2.5
Part 2 2/3 # 5 mmHg 0/3 # 5 mmHg Grade 2 Grade 3
Required $24 #3
Achieved SBP 32 0 Pass Pass
DBP 33 0 Pass Pass
Part 3 PASS
Abbreviations: eSH, european Society for Hypertension; SD, standard deviation (mmHg); SDP, systolic blood pressure; DBP, diastolic blood pressure.
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Table 4 Results of the Omron R2 device according to the eSH international protocol
Phase 1 #5 mmHg #10 mmHg #15 mmHg Recommendation
Required One of 25 35 40
Achieved
SBP 38 41 45 Continue
DBP 37 44 45 Continue
Phase 2.1 #5 mmHg #10 mmHg #15 mmHg Recommendation Mean difference SD
Required Two of 65 80 95
All of 60 75 90
Achieved SBP 81 92 99 Pass −1.1 4.8
DBP 82 94 99 Pass −0.9 4.3
Phase 2.2 2/3 # 5 mmHg 0/3 # 5 mmHg Recommendation
Required $22 #3
Achieved SBP 29 2 Pass
DBP 29 3 Pass
Abbreviations: eSH, european Society for Hypertension; SD, standard deviation (mmHg); SDP, systolic blood pressure; DBP, diastolic blood pressure.
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excessive extension or flexion and without a clenched fist. 
In practice, these recommendations are usually not fully 
followed, so experts prefer to use a device measuring BP 
at the brachial level.
In this study, validation was performed according to the 
international protocol. This protocol was published in 2002 
by the ESH10 aiming to simplify the other two available pro-
tocols, ie, the British Hypertension Society8 and   Association 
for the Advancement of Medical Instrumentation9 protocols, 
without compromising their integrity. The main advantage of 
this protocol is that it requires a smaller number of subjects 
(n = 33) than the 85 required for the two other protocols. 
However, this protocol had some limitations. First, the 
population required in the international protocol is con-
fined to adults .30 years (.25 years in the 2010 revision) 
with specifications in terms of age, gender, BP level, and arm 
circumference. Because this selected population is only a part 
of the large heterogeneous population affected by hyperten-
sion, extrapolation of results to other specific populations 
may be hazardous and risky. Specific validation studies 
are needed if the devices are to be used by specific popula-
tions, eg, pregnant women, the elderly, the obese,   children, 
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Figure 4 Plots of systolic (A) and diastolic (B) blood pressure differences between the OmronR2 readings and the mean of two observer readings in 33 participants (n = 99).Vascular Health and Risk Management
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or patients with specific conditions, such as arrhythmia. 
Second, the number of validation studies needed to confirm 
device accuracy is an important issue. The international 
protocol does not specify the number of devices or study 
sites recommended to optimize accuracy of measurements. 
Experts agree that it would be important to have at least two 
validation studies conducted in different centers and various 
populations. In this regard, the Association for the Advance-
ment of Medical Instrumentation protocol recommends more 
than one study but does not specify the number of studies or 
devices. Therefore, because none of the four tested devices 
in the present study went through prior validation, it would 
be important to undertake at least one further study in a 
specific population before recommending their widespread 
use in the clinic.
Conclusion
The results of the present study show that the four tested 
devices, ie, the Omron M2, Omron M3, and Omron M6 
which measure BP at the brachial level (arm) and the 
Omron R2 which measures the BP at the radial level (wrist) 
meet the requirements of the ESH international protocol and 
its 2010 revision in a general population. Therefore, any of 
these four devices can be used by patients for SBPM if used 
correctly according to the manufacturer recommendations. 
Because of certain limitations of the international protocol, 
it would be desirable to corroborate the present results by 
other studies performed in both the general population and 
in selected patient populations.
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